Phosphotyrosine interactome of the ErbB‐receptor kinase family

Schulze, Waltraud X, Deng, Lei, Mann, Matthias·2005·Molecular Systems Biology

Cited by (754)

Items 101–200 of 754

  1. AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer
    D. Mark Hickinson, Teresa C. M. Klinowska, Georgina Speake, John Vincent, Cath B. Trigwell, Judith Anderton, Sarah Beck, Gayle B. Marshall, Sara Davenport, Rowena J. Callis et al. · 2010 · Clinical Cancer Research
  2. Protein Alterations Associated with Pancreatic Cancer and Chronic Pancreatitis Found in Human Plasma using Global Quantitative Proteomics Profiling
    Sheng Pan, Ru Chen, David A. Crispin, Damon May, Tyler Stevens, Martin W. McIntosh, Mary P. Bronner, Argyrios Ziogas, Hoda Anton‐Culver, Teresa A. Brentnall · 2011 · Journal of Proteome Research
  3. Chemistry meets proteomics: The use of chemical tagging reactions for MS‐based proteomics
    Alexander Leitner, Wolfgang F. Lindner · 2006 · PROTEOMICS
  4. Posttranslational Regulation of CIRCADIAN CLOCK ASSOCIATED1 in the Circadian Oscillator of Arabidopsis
    Esther Yakir, Dror Hilman, Ido Kron, Miriam Hassidim, Naomi Melamed‐Book, Rachel M. Green · 2009 · PLANT PHYSIOLOGY
  5. Acquired Resistance to Small Molecule ErbB2 Tyrosine Kinase Inhibitors
    Franklin L. Chen, Wenle Xia, Neil L. Spector · 2008 · Clinical Cancer Research
  6. Spatial and Temporal Regulation of Receptor Tyrosine Kinase Activation and Intracellular Signal Transduction
    John J.M. Bergeron, Gianni M. Di Guglielmo, Sophie Dahan, Michel Dominguez, Barry I. Posner · 2016 · Annual Review of Biochemistry
  7. Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS
    Udayan Guha, Raghothama Chaerkady, Arivusudar Marimuthu, Angelica Patterson, Manoj Kumar Kashyap, Harsha Gowda, Mitsuo Sato, Joel S. Bader, Alex Lash, John Dorrance Minna et al. · 2008 · Proceedings of the National Academy of Sciences
  8. The role of ErbB4 in cancer
    Vincent F. M. Segers, Lindsey Dugaucquier, Eline Feyen, Hadis Shakeri, Gilles W. De Keulenaer · 2020 · Cellular Oncology
  9. ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling
    Xin Li, Yao‐Kuang Huang, Jing Jiang, Stuart J. Frank · 2008 · Cellular Signalling
  10. Intestinal growth factors: Potential use in the treatment of inflammatory bowel disease and their role in mucosal healing
    Kumar Krishnan, Baron Arnone, Alan L. Buchman · 2010 · Inflammatory Bowel Diseases
  11. Screening for PTB Domain Binding Partners and Ligand Specificity Using Proteome-Derived NPXY Peptide Arrays
    Matthew James Smith, William Rod Hardy, James M. Murphy, Nina Jones, Tony J. Pawson · 2006 · Molecular and Cellular Biology
  12. Regulation of ERBB3/HER3 signaling in cancer
    Kalpana Mujoo, Byung-Kwon Choi, Zhao Huang, Ningyan Zhang, Zhiqiang An · 2014 · Oncotarget
  13. Mechanisms of tumor resistance to EGFR-targeted therapies
    Elizabeth A. Hopper-Borge, Rochelle E. Nasto, Vladimir Ratushny, Louis M. Weiner, Erica A. Golemis, Igor A. Astsaturov · 2009 · Expert Opinion on Therapeutic Targets
  14. Quantitative Glycoproteomics Analysis Reveals Changes in N-Glycosylation Level Associated with Pancreatic Ductal Adenocarcinoma
    Sheng Pan, Ru Chen, Yasuko Tamura, David A. Crispin, Lisa Ann Lai, Damon May, Martin W. McIntosh, David R. Goodlett, Teresa A. Brentnall · 2014 · Journal of Proteome Research
  15. Batch Normalizer: A Fast Total Abundance Regression Calibration Method to Simultaneously Adjust Batch and Injection Order Effects in Liquid Chromatography/Time-of-Flight Mass Spectrometry-Based Metabolomics Data and Comparison with Current Calibration Methods
    San‐Yuan Wang, Ching‐Hua Kuo, Yufeng Jane Tseng · 2012 · Analytical Chemistry
  16. Comprehensive reanalysis of transcription factor knockout expression data in Saccharomyces cerevisiae reveals many new targets
    Jüri Reimand, Juan M. Vaquerizas, Annabel E. Todd, Jaak Vilo, Nicholas M. Luscombe · 2010 · Nucleic Acids Research
  17. Profiling of Protein Interaction Networks of Protein Complexes Using Affinity Purification and Quantitative Mass Spectrometry
    Robyn M. Kaake, Xiaorong Wang, Lan Huang · 2010 · Molecular & Cellular Proteomics
  18. Oncogenic Mutations Rewire Signaling Pathways by Switching Protein Recruitment to Phosphotyrosine Sites
    Alicia Lundby, Giulia Franciosa, Kristina Bennet Emdal, Jan C. Refsgaard, Sebastian Peter Gnosa, Dorte B. Bekker‐Jensen, Anna Secher, Svetlana Rajkumar Maurya, Indranil Paul, Blanca Lopez Mendez et al. · 2019 · Cell
  19. A novel far-red bimolecular fluorescence complementation system that allows for efficient visualization of protein interactions under physiological conditions
    Jun Chu, Zhihong Zhang, Ying Yi Zheng, Jie Yang, Lingsong Qin, Jinling Lu, Zhen‐Li Huang, Shaoqun Zeng, Qingming Luo · 2009 · Biosensors and Bioelectronics
  20. The application of systems biology to drug discovery
    Carolyn R. Cho, Mark Labow, Mischa Reinhardt, Jan van Oostrum, Manuel C. Peitsch · 2006 · Current Opinion in Chemical Biology
  21. Yeast Functional Genomic Screens Lead to Identification of a Role for a Bacterial Effector in Innate Immunity Regulation
    Roger Kramer, Naomi L Slagowski, Ngozi A. Eze, Kara Sue Giddings, Monica F Morrison, Keri A. Siggers, Michael N. Starnbach, Cammie F. Lesser · 2007 · PLoS Pathogens
  22. Gain and loss of phosphorylation sites in human cancer
    Predrag Radivojac A, Peter H. Baenziger, Maricel G. Kann, Matthew E. Mort, Matthew W. Hahn, Sean David Mooney · 2008 · Bioinformatics
  23. The social network of a cell: Recent advances in interactome mapping
    Sébastian Charbonnier, Oriol Gallego, Anne‐Claude Gavin · 2008 · Biotechnology annual review
  24. Quantitative proteomics and phosphoproteomics reveal novel insights into complexity and dynamics of the EGFR signaling network
    Sandra Morandell, Taras Stasyk, Sergej Skvortsov, Stefan Ascher, Lukas Alfons Huber · 2008 · PROTEOMICS
  25. EGF receptor signaling blocks aryl hydrocarbon receptor-mediated transcription and cell differentiation in human epidermal keratinocytes
    Thomas R. Sutter, Hong Yin, Yunbo Li, Jennifer Sophie Mammen, Sridevi Bodreddigari, Gaylene Stevens, Judith A. Cole, Thomas R. Sutter · 2009 · Proceedings of the National Academy of Sciences
  26. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function
    Rumey C. Ishizawar, T Miyake, Sarah J. Parsons · 2006 · Oncogene
  27. erbB3 Is an Active Tyrosine Kinase Capable of Homo- and Heterointeractions
    Mara P. Steinkamp, Shalini T. Low-Nam, Shujie Yang, Keith A. Lidke, Diane S. Lidke, Bridget Smith Wilson · 2013 · Molecular and Cellular Biology
  28. FIONA1 Is Essential for Regulating Period Length in the Arabidopsis Circadian Clock
    Jeongsik Kim, Yumi Kim, Miji Yeom, Jin‐Hee Kim, Hong Gil Nam · 2008 · The Plant Cell
  29. Resistance to Intervention: Paclitaxel in Breast Cancer
    Vipin Mohan Dan, Reji Saradha Raveendran, Sabulal Baby · 2020 · Mini-Reviews in Medicinal Chemistry
  30. HER4 Intracellular Domain (4ICD) Activity in the Developing Mammary Gland and Breast Cancer
    Frank E. Jones · 2008 · Journal of Mammary Gland Biology and Neoplasia
  31. Role of Duplicate Genes in Robustness against Deleterious Human Mutations
    Tzu‐Lin Hsiao, Dennis Vitkup · 2008 · PLoS Genetics
  32. Mapping ErbB receptors on breast cancer cell membranes during signal transduction
    Shujie Yang, Mary Ann Raymond‐Stintz, Wenxia Ying, Jun Zhang, Diane S. Lidke, Stanly L. Steinberg, Lance R. Williams, Janet M. Oliver, Bridget Smith Wilson · 2007 · Journal of Cell Science
  33. A Complex Genetic Interaction BetweenArabidopsis thalianaTOC1 and CCA1/LHY in Driving the Circadian Clock and in Output Regulation
    Zhaojun Ding, Mark R. Doyle, Richard M. Amasino, Seth J Davis · 2007 · Genetics
  34. Protein function prediction by massive integration of evolutionary analyses and multiple data sources
    Domenico Cozzetto, Daniel W. A. Buchan, Kevin Bryson, David T. Jones · 2013 · BMC Bioinformatics
  35. Dynamic Profiling of the Post-translational Modifications and Interaction Partners of Epidermal Growth Factor Receptor Signaling after Stimulation by Epidermal Growth Factor Using Extended Range Proteomic Analysis (ERPA)
    Shiaw‐Lin Wu, Jeongkwon Kim, Russell Bandle, Lance A. Liotta, Emanuel F. Petricoin, Barry L. Karger · 2006 · Molecular & Cellular Proteomics
  36. Automated typing of red blood cell and platelet antigens: a whole-genome sequencing study
    William J. Lane, Connie M. Westhoff, Nicholas Gleadall, Maria D. Aguad, Robin Smeland‐Wagman, Sunitha Vege, Daimon P. Simmons, Helen H. Mah, Matthew S. Lebo, Klaudia Walter et al. · 2018 · The Lancet Haematology
  37. Can EGFR be a therapeutic target in breast cancer?
    Xi‐Yin Li, Lina Zhao, Ceshi Chen, Jianyun Nie, Baowei Jiao · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  38. Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis
    David J. Riese, Richard M. Gallo, Jeffrey E. Settleman · 2007 · BioEssays
  39. Metabolic labeling of plant cell cultures with K15NO3 as a tool for quantitative analysis of proteins and metabolites
    Wolfgang R. Engelsberger, Alexander Erban, Joachim Kopka, Waltraud X. Schulze · 2006 · Plant Methods
  40. Teaching an old dogma new tricks: twenty years of Shc adaptor signalling
    Melanie K. B. Wills, Nina Jones · 2012 · Biochemical Journal
  41. The EGFR network in bone biology and pathology
    Marlon Roberto Schneider, Maria Chiara Sibilia, Reinhold G. Erben · 2009 · Trends in Endocrinology and Metabolism
  42. SLoMo: Automated Site Localization of Modifications from ETD/ECD Mass Spectra
    Christopher M. Bailey, Steve M. M. Sweet, Debbie L. Cunningham, Martin Zeller, John K. Heath, Helen J. Cooper · 2009 · Journal of Proteome Research
  43. Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma
    Andre Cassell, Jennifer Rubin Grandis · 2010 · Expert Opinion on Investigational Drugs
  44. Phosphotyrosine recognition domains: the typical, the atypical and the versatile
    Tomonori Kaneko, Rakesh Joshi, Stephan M. Feller, Shawn S.‐C. Li · 2012 · Cell Communication and Signaling
  45. Pathway-Based Biomarker Search by High-Throughput Proteomics Profiling of Secretomes
    Kevin Lawlor, Arpi Nazarian, Lynne Lacomis, Paul Tempst, Josep Villanueva · 2009 · Journal of Proteome Research
  46. Methods, algorithms and tools in computational proteomics: A practical point of view
    Rune Matthiesen · 2007 · PROTEOMICS
  47. Distinct Light and Clock Modulation of Cytosolic Free Ca2+ Oscillations and RhythmicCHLOROPHYLL A/B BINDING PROTEIN2Promoter Activity inArabidopsis
    Xiaodong Xu, Carlos Takeshi Hotta, Antony N. Dodd, John Love, Robert Sharrock, Young Wha Lee, Qiguang Xie, Carl Hirschie Johnson, Alex A. R. Webb · 2007 · The Plant Cell
  48. Early signaling dynamics of the epidermal growth factor receptor
    Raven J. Reddy, Aaron S. Gajadhar, Eric J. Swenson, Daniel A. Rothenberg, Timothy G. Curran, Forest M. White · 2016 · Proceedings of the National Academy of Sciences
  49. Disease-associated glycans on cell surface proteins
    Motoko Takahashi, Yasuhiko Kizuka, Kazuaki Ohtsubo, Jianguo Gu, Naoyuki Taniguchi · 2016 · Molecular Aspects of Medicine
  50. ErbB2 signaling at the crossing between heart failure and cancer
    Zarha Vermeulen, Vincent F. M. Segers, Gilles W. De Keulenaer · 2016 · Basic Research in Cardiology
  51. Making Knowledge in Synthetic Biology: Design Meets Kludge
    Maureen A. O’Malley · 2009 · Biological Theory
  52. ErbB signaling in cardiac development and disease
    Pablo Sanchez-Soria, Todd D. Camenisch · 2010 · Seminars in Cell and Developmental Biology
  53. The Role of ErbB3 and its Binding Partners in Breast Cancer Progression and Resistance to Hormone and Tyrosine Kinase Directed Therapies
    Anne W. Hamburger · 2008 · Journal of Mammary Gland Biology and Neoplasia
  54. Strong EGFR signaling in cell line models of ERBB2-amplified breast cancer attenuates response towards ERBB2-targeting drugs
    Frauke Henjes, Christian Bender, Silvia von der Heyde, Lisa Braun, Heiko Mannsperger, C Schmidt, Stefan Wiemann, Max Hasmann, Sebastian Aulmann, Tim Beißbarth et al. · 2012 · Oncogenesis
  55. Quantitative proteomics as a new piece of the systems biology puzzle
    Angela Bachi, Tiziana Bonaldi · 2008 · Journal of Proteomics
  56. Proteomic analysis of phosphorylation, oxidation and nitrosylation in signal transduction
    Corinne Michelle Spickett, Andrew R. Pitt, Nicholas A. Morrice, Walter Kölch · 2006 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  57. Selective Raf inhibition in cancer therapy
    Vladimir Khazak, Igor A. Astsaturov, Ilya G. Serebriiskii, Erica A. Golemis · 2007 · Expert Opinion on Therapeutic Targets
  58. Kinetic insulation as an effective mechanism for achieving pathway specificity in intracellular signaling networks
    Marcelo Behar, Henrik Gunnar Dohlman, Timothy C. Elston · 2007 · Proceedings of the National Academy of Sciences
  59. Protein-tyrosine Phosphatase PTPN9 Negatively Regulates ErbB2 and Epidermal Growth Factor Receptor Signaling in Breast Cancer Cells
    Taichang Yuan, Yongping Wang, Zhizhuang Joe Zhao, Haihua Gu · 2010 · Journal of Biological Chemistry
  60. Epidermal Growth Factor Receptor Phosphorylation Sites Ser991 and Tyr998 Are Implicated in the Regulation of Receptor Endocytosis and Phosphorylations at Ser1039 and Thr1041
    Jiefei Tong, Paul P. Taylor, Scott M. Peterman, Amol Prakash, Michael F. Moran · 2009 · Molecular & Cellular Proteomics
  61. Cell and Molecular Biology of Epidermal Growth Factor Receptor
    Brian P. Ceresa, Joanne L. Peterson · 2014 · International review of cytology
  62. Combinatorial proteomic analysis of intercellular signaling applied to the CD28 T-cell costimulatory receptor
    Ruijun Tian, Haopeng Wang, Gerald D. Gish, Evangelia Petsalaki, Adrian Pasculescu, Yu Shi, Marianne Newton Mollenauer, Richard D. Bagshaw, Nir Yosef, Tony R. Hunter et al. · 2015 · Proceedings of the National Academy of Sciences
  63. The Geometry of Multisite Phosphorylation
    Arjun Kumar Manrai, Jeremy Gunawardena · 2008 · Biophysical Journal
  64. Serine Phosphorylation of the Integrin β4 Subunit Is Necessary for Epidermal Growth Factor Receptor–induced Hemidesmosome Disruption
    Kevin Wilhelmsen, Sandy H.M. Litjens, Ingrid Kuikman, Coert Margadant, Jacco van Rheenen, Arnoud Sonnenberg · 2007 · Molecular Biology of the Cell
  65. Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors
    Saveria Pastore, Daniela Lulli, Giampiero Girolomoni · 2014 · Archives of Toxicology
  66. The Under-Appreciated Promiscuity of the Epidermal Growth Factor Receptor Family
    Sean P. Kennedy, Jordan F. Hastings, Jeremy Z. R. Han, David R. Croucher · 2016 · Frontiers in Cell and Developmental Biology
  67. Mechanisms of Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) Action in Human Neoplasia
    Laurel E. Black, Jody Fromm Longo, Steven Lewis Carroll · 2019 · American Journal Of Pathology
  68. Targeting EGFR resistance networks in head and neck cancer
    Vladimir Ratushny, Igor A. Astsaturov, Barbara Ann Burtness, Erica A. Golemis, Joshua Seth Silverman · 2009 · Cellular Signalling
  69. Uniformly curated signaling pathways reveal tissue-specific cross-talks and support drug target discovery
    Tamás Korcsmáros, Illés J. Farkas, Máté Szalay, Petra Rovó, Dávid Fazekas, Zoltán Spiró, Csaba Böde, Katalin Lenti, Tibor Vellai, Péter Csermely · 2010 · Bioinformatics
  70. Recombinant bacteria for environmental release: what went wrong and what we have learnt from it
    Vı́ctor de Lorenzo · 2009 · Clinical Microbiology and Infection
  71. Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors
    Thomas Frogne, Anne‐Vibeke Lænkholm, Maria Lyng, Katrine L. Henriksen, Anne E. Lykkesfeldt · 2009 · Breast Cancer Research
  72. The ErbB2 Signaling Network as a Target for Breast Cancer Therapy
    Ali Badache, Anthony Gonçalvès · 2006 · Journal of Mammary Gland Biology and Neoplasia
  73. Inhibition of doxorubicin‐induced HER3‐PI3K‐AKT signalling enhances apoptosis of ovarian cancer cells
    Martin Bezler, Jan Georg Hengstler, Axel Ullrich · 2012 · Molecular Oncology
  74. The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein
    Lucas, Lauren M., Dwivedi, Vipasha, Senfeld, Jared I., Cullum, Richard L., Mill, Christopher P., Piazza, J. Tyler, Bryant, Ianthe N., Cook, Laura J., Miller, S. Tyler, Lott, James H. et al. · 2022 · Pharmacological Reviews
  75. Detection of EGFR and KRAS mutations on trans-thoracic needle aspiration of lung nodules by high resolution melting analysis
    Ambrogio Fassina, A Gazziero, Davide Zardo, Matteo Corradin, Enrico Aldighieri, Gian Paolo Rossi · 2009 · Journal of Clinical Pathology
  76. Development of Effective Therapeutics Targeting HER3 for Cancer Treatment
    Xiaolong Liu, Shuang Liu, Hui Lyu, Adam I. Riker, Yamin Zhang, Bolin Liu · 2019 · Biological Procedures Online
  77. Phosphotyrosine mediated protein interactions of the discoidin domain receptor 1
    Simone Lemeer, Andrej Bluwstein, Zhixiang Wu, Julia Leberfinger, Konrad Müller, Karl Kramer, Bernhard Küster · 2011 · Journal of Proteomics
  78. Modelling Biological Rhythms
    Till Roenneberg, Elaine Jane Chua, Ric Bernardo, Eduardo Mendoza · 2008 · Current Biology
  79. Antibody–Drug Conjugates for the Treatment of Breast Cancer
    Chiara Corti, Federica Giugliano, Eleonora Nicolò, Liliana Ascione, Giuseppe Curigliano · 2021 · Cancers
  80. A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells
    Bizhu Chu, F Liu, L Li, C Ding, K Chen, Q Sun, Zhifa Shen, Y Tan, Chunyan Tan, Yuyang Jiang · 2015 · Cell Death and Disease
  81. Beta 2 glycoprotein I is a substrate of thiol oxidoreductases
    Freda H. Passam, Soheila Rahgozar, Miao Qi, Mark J. Raftery, Jason W.H. Wong, Kumiko Tanaka, Yiannis Ioannou, Jing Yun Zhang, Rosalie Gemmell, Jian Chen Qi et al. · 2010 · Blood
  82. Role of the Slt2 mitogen-activated protein kinase pathway in cell wall integrity and virulence in Candida glabrata: Role of the Slt2 MAPK pathway in C. glabrata
    Miyazaki, Taiga, Inamine, Tatsuo, Yamauchi, Shunsuke, Nagayoshi, Yosuke, Saijo, Tomomi, Izumikawa, Koichi, Seki, Masafumi, Kakeya, Hiroshi, Yamamoto, Yoshihiro, Yanagihara, Katsunori et al. · 2010 · FEMS Yeast Research
  83. Autoantibody-Specific Signalling in Pemphigus
    Thomas Schmitt, Jens Waschke · 2021 · Frontiers in Medicine
  84. Comparative Genomic and Proteomic Analysis of Cytoskeletal Changes in Dexamethasone-Treated Trabecular Meshwork Cells
    Ross W. Clark, Amanda K. Nosie, Teresa M. Walker, Jennifer A. Faralli, Mark S. Filla, Gregory A. Barrett‐Wilt, Donna M. Pesciotta Peters · 2012 · Molecular & Cellular Proteomics
  85. Wide-Scale Analysis of Human Functional Transcription Factor Binding Reveals a Strong Bias towards the Transcription Start Site
    Yuval Tabach, Ran Brosh, Yossi Buganim, Anat Reiner Benaim, Or Zuk, Assif Yitzhaky, Mark Koudritsky, Varda Rotter, Eytan Domany · 2007 · PLoS ONE
  86. Differential network analysis for the identification of condition-specific pathway activity and regulation
    Gennaro Gambardella, Maria Nicoletta Moretti, Rossella De Cegli, Luca Cardone, Adriano Peron, Diego di Bernardo · 2013 · Bioinformatics
  87. A Cell-Targeted Photodynamic Nanomedicine Strategy for Head and Neck Cancers
    Аlyssa M. Master, Anthony S. Malamas, Rachna Solanki, Dana M. Clausen, Julie L. Eiseman, Anirban Sen Gupta · 2013 · Molecular Pharmaceutics
  88. Mass Spectrometry Mapping of Epidermal Growth Factor Receptor Phosphorylation Related to Oncogenic Mutations and Tyrosine Kinase Inhibitor Sensitivity
    Guolin Zhang, Bin Fang, Richard Z. Liu, Hui‐Yi Lin, Fumi Kinose, Yun Bai, Umut Oguz, Elizabeth R. Remily-Wood, Jiannong Li, Soner Altiok et al. · 2010 · Journal of Proteome Research
  89. Predicting time to ovarian carcinoma recurrence using protein markers
    Ji-Yeon Yang, Kosuke Yoshihara, Kenichi Tanaka, Masayuki Hatae, Hideaki Masuzaki, Hiroaki Itamochi, Masashi Takano, Kimio Ushijima, Janos Laszlo Tanyi, George Coukos et al. · 2013 · Journal of Clinical Investigation
  90. Computational study of molecular electrostatic potential, docking and dynamics simulations of gallic acid derivatives as ABL inhibitors
    K. R. Raghi, Daisy Rajaian Sherin, M. J. Saumya, P.S. Arun, V.N. Sobha, Thanathu Krishnan Manojkumar · 2018 · Computational Biology and Chemistry
  91. SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor
    Chengyao Chiang, Chin‐Chen Pan, Hong Chang, Ming-Derg Lai, Tzong‐Shin Tzai, Yuh‐Shyan Tsai, Pin Ling, Hsiao‐Sheng Liu, Bi‐Fang Lee, Hong-Ling Cheng et al. · 2015 · Clinical Cancer Research
  92. The anti-erbB3 antibody MM-121/SAR256212 in combination with trastuzumab exerts potent antitumor activity against trastuzumab-resistant breast cancer cells
    Jingcao Huang, Shuiliang Wang, Hui Lyu, Bo Cai, Xiaohe Yang, Jianxiang Wang, Bolin Liu · 2013 · Molecular Cancer
  93. The Therapeutic Potential of MAPK/ERK Inhibitors in the Treatment of Colorectal Cancer
    Mehran Pashirzad, Reihaneh Khorasanian, Maryam Mahmoudi Fard, Mohammad‐Hassan Arjmand, Hadis Langari, Majid Khazaei, Saman Soleimanpour, Majid Rezayi, Gordon A. Ferns, Seyed Mahdi Hassanian et al. · 2021 · Current Cancer Drug Targets
  94. UV‐induced EGFR signal transactivation is dependent on proligand shedding by activated metalloproteases in skin cancer cell lines
    Bhuminder Singh, Matthias Schneider, Pjotr G. Knyazev, Axel Ullrich · 2008 · International Journal of Cancer
  95. Humoral Response Profiling Reveals Pathways to Prostate Cancer Progression
    Barry S. Taylor, Manoj Kumar Pal, Jianjun Yu, Bharathi Laxman, Shanker Kalyana Sundaram, Rong Zhao, Anjana Menon, John Thomas Wei, Alexey I. Nesvizhskii, Debashis Ghosh et al. · 2007 · Molecular & Cellular Proteomics
  96. Signaling through ShcA Is Required for Transforming Growth Factor β- and Neu/ErbB-2-Induced Breast Cancer Cell Motility and Invasion
    J. J. Northey, J. Chmielecki, E. Ngan, C. Russo, M. Annis, W. Muller, P. Siegel · 2008 · Molecular and Cellular Biology
  97. Somatic Mutations of ErbB4
    Denis Tvorogov, Maria Sundvall, Kari J. Kurppa, Maija Hollmén, Susanna Repo, Mark S. Johnson, Klaus Elenius · 2008 · Journal of Biological Chemistry
  98. A computational genomics approach to identify cis-regulatory modules from chromatin immunoprecipitation microarray data—A case study using E2F1
    Victor X. Jin, Alina Rabinovich, Sharon L. Squazzo, Roland Green, Peggy Farnham · 2006 · Genome Research
  99. HER family in cancer progression: From discovery to 2020 and beyond
    Rakesh Kumar, Bijesh George, Marcia R. Campbell, Nandini Verma, Aswathy Mary Paul, Cecília Melo-Alvim, Leonor Ribeiro, M. Radhakrishna Pillai, Luís Costa, Mark M. Moasser · 2020 · Advances in cancer research
  100. Synthetic Lethal Screens Identify Gene Silencing Processes in Yeast and Implicate the Acetylated Amino Terminus of Sir3 in Recognition of the Nucleosome Core
    T. van Welsem, Floor Frederiks, K. Verzijlbergen, A. W. Faber, Zara W. Nelson, D. Egan, D. Gottschling, F. van Leeuwen · 2008 · Molecular and Cellular Biology